| Yale University School of Medicine |
cohort |
6 |
3 |
APT Foundation, Yale, Yale Med Cohort |
| yawning |
phenotype |
2 |
2 |
|
| Y chromosome |
drug |
2 |
1 |
|
| years of education |
phenotype |
8 |
6 |
EDY, education, education years, educational attainment |
| yeast |
cohort |
7 |
3 |
S. cerevisiae, YEAST |
| yellow module |
cohort |
2 |
1 |
|
| YFS |
cohort |
2 |
1 |
Young Finns Study |
| Ym1 |
gene |
2 |
2 |
Chil3, M2 marker YM1, YM1, chitinase 3-like 3 |
| yohimbine |
drug |
3 |
1 |
α-2 adrenoceptor antagonist |
| Yoruba |
cohort |
8 |
3 |
YRI, Yoruba, Yoruba population, Yoruba sample, Yoruban population |
| Young Adult Alcohol Problems Screening Test |
phenotype |
2 |
1 |
YAAPST |
| Young adult cohort |
cohort |
6 |
3 |
population-based sample of young adults, young adult cohort, young adults |
| young adults |
cohort |
70 |
40 |
1,399,489 young adults, 18–29 years of age, age 30–44, ages 12-31, early adulthood, participants, trauma-exposed young adults, young adult, young adult community sample, young adult group, young adult participants, young adult period, young adult population, young adult sample, young adulthood, young adults, young adults (age 18-28), young adults (ages 12 to 25), ≥ 19 years |
| Young alcoholics |
phenotype |
2 |
— |
|
| Younger adults |
cohort |
4 |
3 |
young adults, younger, younger counterparts |
| younger cohort |
cohort |
15 |
6 |
MTFS, MTFS younger cohort, Phase 2, age 11 cohort, age: younger, younger cohort, younger participants, younger populations |
| younger participants |
cohort |
2 |
— |
younger participants |
| young men |
cohort |
3 |
2 |
578 young men, participants, young men |
| young mice |
cohort |
5 |
1 |
young animals |
| young women |
cohort |
6 |
4 |
women, young women |
